Wealthfront Advisers LLC lifted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) by 4.6% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 87,087 shares of the pharmacy operator's stock after acquiring an additional 3,798 shares during the period. Wealthfront Advisers LLC's holdings in Walgreens Boots Alliance were worth $3,301,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Rise Advisors LLC bought a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $27,000. City State Bank bought a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $30,000. Iron Horse Wealth Management LLC increased its position in Walgreens Boots Alliance by 56.0% in the 1st quarter. Iron Horse Wealth Management LLC now owns 635 shares of the pharmacy operator's stock worth $28,000 after buying an additional 228 shares during the period. GoalVest Advisory LLC increased its position in Walgreens Boots Alliance by 10,828.6% in the 2nd quarter. GoalVest Advisory LLC now owns 765 shares of the pharmacy operator's stock worth $29,000 after buying an additional 758 shares during the period. Finally, Tompkins Financial Corp increased its position in Walgreens Boots Alliance by 215.7% in the 1st quarter. Tompkins Financial Corp now owns 947 shares of the pharmacy operator's stock worth $42,000 after buying an additional 647 shares during the period. 57.33% of the stock is owned by institutional investors.
Get Walgreens Boots Alliance alerts:Walgreens Boots Alliance Price Performance
Shares of WBA stock opened at $31.40 on Friday. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.78 and a quick ratio of 0.43. The firm has a market cap of $27.14 billion, a price-to-earnings ratio of 5.06, a P/E/G ratio of 1.37 and a beta of 0.62. The stock's fifty day simple moving average is $36.70 and its 200 day simple moving average is $40.63. Walgreens Boots Alliance, Inc. has a one year low of $31.23 and a one year high of $55.00.
Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last posted its quarterly earnings data on Thursday, June 30th. The pharmacy operator reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.95 by $0.01. The company had revenue of $32.60 billion for the quarter, compared to analyst estimates of $32.23 billion. Walgreens Boots Alliance had a return on equity of 16.20% and a net margin of 4.00%. The business's revenue was down 4.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.51 earnings per share. On average, analysts expect that Walgreens Boots Alliance, Inc. will post 5.02 earnings per share for the current fiscal year.Walgreens Boots Alliance Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 9th. Shareholders of record on Friday, August 19th were paid a $0.48 dividend. The ex-dividend date of this dividend was Thursday, August 18th. This represents a $1.92 dividend on an annualized basis and a yield of 6.11%. This is a positive change from Walgreens Boots Alliance's previous quarterly dividend of $0.48. Walgreens Boots Alliance's payout ratio is currently 30.97%.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on WBA shares. Deutsche Bank Aktiengesellschaft lowered their price objective on Walgreens Boots Alliance from $44.00 to $38.00 and set a "hold" rating on the stock in a research report on Thursday, September 22nd. Barclays lowered their price objective on Walgreens Boots Alliance from $50.00 to $45.00 and set an "equal weight" rating on the stock in a research report on Friday, June 24th. JPMorgan Chase & Co. lowered their price objective on Walgreens Boots Alliance from $52.00 to $45.00 and set a "neutral" rating on the stock in a research report on Friday, July 8th. Cowen lowered their price objective on Walgreens Boots Alliance to $49.00 in a research report on Thursday, June 9th. Finally, Truist Financial lowered their price objective on Walgreens Boots Alliance from $50.00 to $42.00 and set a "hold" rating on the stock in a research report on Friday, July 1st. One research analyst has rated the stock with a sell rating and nine have assigned a hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $45.75.
Walgreens Boots Alliance Company Profile
(Get Rating)
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Read More
- Get a free copy of the StockNews.com research report on Walgreens Boots Alliance (WBA)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.